Timing for deep vein thrombosis chemoprophylaxis in traumatic brain injury: An evidence-based review

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Abdel Aziz, Hiba ^a   Dunham, C Michael ^a   Malik, Rema J ^a   Hileman, Barbara M ^a  

^a ST ELIZABETH HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

BRAIN CONTUSION; BRAIN HEMORRHAGE; CHEMOPROPHYLAXIS; DEEP VEIN THROMBOSIS; DIFFUSE AXONAL INJURY; DISEASE COURSE; EPIDURAL HEMATOMA; EVIDENCE BASED PRACTICE; HIGH RISK PATIENT; HUMAN; LOW RISK PATIENT; PRIORITY JOURNAL; REVIEW; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; THROMBOSIS PREVENTION; TIME TO TREATMENT; TRAUMATIC BRAIN INJURY; BRAIN INJURIES; CHEMICALLY INDUCED; COMPLICATION; INTRACRANIAL HEMORRHAGES; RISK FACTOR; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

ANTICOAGULANTS; BRAIN INJURIES; ENOXAPARIN; HUMANS; INTRACRANIAL HEMORRHAGES; RISK FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84925325938     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-0814-z     Document Type: Review

References (30)

1. Phelan HA. Pharmacologic venous thromboembolism prophylaxis after traumatic brain injury: a critical literature review. J Neurotrauma. 2012;29:1821-8.
2. Scales DC, Riva-Cambrin J, Wells D, Athaide V, Granton JT, Detsky AS. Prophylactic anticoagulation to prevent venous thromboembolism in traumatic intracranial hemorrhage: a decision analysis. Crit Care. 2010;14:R72.
3. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331:1601-6.
4. Bee TK, Magnotti LJ, Croce MA, Maish GO, Minard G, Schroeppel TJ, et al. Necessity of repeat head CT and ICU monitoring in patients with minimal brain injury. J Trauma. 2009;66:1015-8.
5. Chang EF, Meeker M, Holland MC. Acute traumatic intraparenchymal hemorrhage: risk factors for progression in the early post-injury period. Neurosurgery. 2006;58:647-56. discussion 647-56.
6. Park HK, Joo WI, Chough CK, Cho CB, Lee KJ, Rha HK. The clinical efficacy of repeat brain computed tomography in patients with traumatic intracranial haemorrhage within 24 hours after blunt head injury. Br J Neurosurg. 2009;23:617-21.
7. Velmahos GC, Gervasini A, Petrovick L, Dorer DJ, Doran ME, Spaniolas K, et al. Routine repeat head CT for minimal head injury is unnecessary. J Trauma. 2006;60:494-9. discussion 499-501.
8. Bratton SL, Chestnut RM, Ghajar J, McConnell Hammond FF, Harris OA, Hartl R, et al. Guidelines for the management of severe traumatic brain injury. V. Deep vein thrombosis prophylaxis. J Neurotrauma. 2007;24:S32-6.
9. Sauaia A, Moore EE, Crebs JL, Maier RV, Hoyt DB, Shackford SR. Evidence level of individual studies: a proposed framework for surgical research. J Trauma Acute Care Surg. 2012;72:1484-90.
10. Kwiatt ME, Patel MS, Ross SE, Lachant MT, MacNew HG, Ochsner MG, et al. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study. J Trauma Acute Care Surg. 2012;73:625-8.
11. Levy AS, Salottolo K, Bar-Or R, Offner P, Mains C, Sullivan M, et al. Pharmacologic thromboprophylaxis is a risk factor for hemorrhage progression in a subset of patients with traumatic brain injury. J Trauma. 2010;68:886-94.
12. Minshall CT, Eriksson EA, Leon SM, Doben AR, McKinzie BP, Fakhry SM. Safety and efficacy of heparin or enoxaparin prophylaxis in blunt trauma patients with a head abbreviated injury severity score >2. J Trauma. 2011;71:396-9. discussion 399-400.
13. Norwood SH, McAuley CE, Berne JD, Vallina VL, Kerns DB, Grahm TW, et al. Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries. Arch Surg. 2002;137:696-701. discussion 701-2.
14. Norwood SH, Berne JD, Rowe SA, Villarreal DH, Ledlie JT. Early venous thromboembolism prophylaxis with enoxaparin in patients with blunt traumatic brain injury. J Trauma. 2008;65:1021-6. discussion 1026-7.
15. Saadeh Y, Gohil K, Bill C, Smith C, Morrison C, Mosher B, et al. Chemical venous thromboembolic prophylaxis is safe and effective for patients with traumatic brain injury when started 24 hours after the absence of hemorrhage progression on head CT. J Trauma Acute Care Surg. 2012;73:426-30.
16. Phelan HA, Eastman AL, Madden CJ, Aldy K, Berne JD, Norwood SH, et al. TBI risk stratification at presentation: a prospective study of the incidence and timing of radiographic worsening in the Parkland Protocol. J Trauma Acute Care Surg. 2012;73:S122-7.
17. Dudley RR, Aziz I, Bonnici A, Saluja RS, Lamoureux J, Kalmovitch B, et al. Early venous thromboembolic event prophylaxis in traumatic brain injury with low-molecular-weight heparin: risks and benefits. J Neurotrauma. 2010;27:2165-72.
18. Kim J, Gearhart MM, Zurick A, Zuccarello M, James L, Luchette FA. Preliminary report on the safety of heparin for deep venous thrombosis prophylaxis after severe head injury. J Trauma. 2002;53:38-42. discussion 43.
19. Koehler DM, Shipman J, Davidson MA, Guillamondegui O. Is early venous thromboembolism prophylaxis safe in trauma patients with intracranial hemorrhage. J Trauma. 2011;70:324-9.
20. Kurtoglu M, Yanar H, Bilsel Y, Guloglu R, Kizilirmak S, Buyukkurt D, et al. Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin. World J Surg. 2004;28:807-11.
21. Cothren CC, Smith WR, Moore EE, Morgan SJ. Utility of once-daily dose of low-molecular-weight heparin to prevent venous thromboembolism in multisystem trauma patients. World J Surg. 2007;31:98-104.
22. Depew AJ, Hu CK, Nguyen AC, Driessen N. Thromboembolic prophylaxis in blunt traumatic intracranial hemorrhage: a retrospective review. Am Surg. 2008;74:906-11.
23. Kleindienst A, Harvey HB, Mater E, Bronst J, Flack J, Herenz K, et al. Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery. Acta Neurochirurgica. 2003;145:1085-90. discussion 1090-1.
24. Norwood SH, McAuley CE, Berne JD, Vallina VL, Kerns DB, Grahm TW, et al. A potentially expanded role for enoxaparin in preventing venous thromboembolism in high risk blunt trauma patients. J Am College Surg. 2001;192:161-7.
25. Pahatouridis D, Alexiou GA, Zigouris A, Mihos E, Drosos D, Voulgaris S. Coagulopathy in moderate head injury. The role of early administration of low molecular weight heparin. Brain Injury. 2010;24:1189-92.
26. Phelan HA, Wolf SE, Norwood SH, Aldy K, Brakenridge SC, Eastman AL, et al. A randomized, double-blinded, placebo-controlled pilot trial of anticoagulation in low-risk traumatic brain injury: The Delayed Versus Early Enoxaparin Prophylaxis I (DEEP I) study. J Trauma Acute Care Surg. 2012;73:1434-41.
27. Salottolo K, Offner P, Levy AS, Mains CW, Slone DS, Bar-Or D. Interrupted pharmocologic thromboprophylaxis increases venous thromboembolism in traumatic brain injury. J Trauma. 2011;70:19-24. discussion 25-6.
28. Arnold JD, Dart BW, Barker DE, Maxwell RA, Burkholder HC, Mejia VA, et al. Gold Medal Forum Winner. Unfractionated heparin three times a day versus enoxaparin in the prevention of deep vein thrombosis in trauma patients. Am Surg. 2010;76:563-70.
29. Scudday T, Brasel K, Webb T, Codner P, Somberg L, Weigelt J, et al. Safety and efficacy of prophylactic anticoagulation in patients with traumatic brain injury. J Am College Surg. 2011;213:148-53. discussion 153-4.
30. Chelladurai Y, Stevens KA, Haut ER, Brotman DJ, Sharma R, Shermock KM, et al. Venous thromboembolism prophylaxis in patients with traumatic brain injury: a systematic review. F1000 Res. 2013;2:132.